Comparative study of ovarian clear cell carcinoma with and without endometriosis in People's Republic of China
- PMID: 25256925
- DOI: 10.1016/j.fertnstert.2014.08.008
Comparative study of ovarian clear cell carcinoma with and without endometriosis in People's Republic of China
Abstract
Objective: To analyze and compare the clinicopathological features and prognosis of ovarian clear cell carcinoma (CCC) with or without endometriosis in Chinese patients.
Design: Comparative study based on a retrospective review of medical charts.
Setting: A general university hospital.
Patient(s): Two hundred ten patients diagnosed and treated with ovarian CCC between 2000 and 2012.
Intervention(s): Patients were divided into two groups depending on coexisting endometriosis. A comparison of clinicopathological characteristics was performed. The Kaplan-Meier model and Cox regression were employed in survival analysis.
Main outcome measure(s): Clinicopathological parameters and survival outcomes.
Result(s): Of 210 patients, 79 (37.6%) were confirmed to have concurrent endometriosis. Patients with endometriosis were 8 years younger than those without. They were more likely to present at early stage (78.5%) with resectable tumors in primary surgery (with optimal cytoreduction rate at 89.9%) and platinum-sensitive disease (51.7%). Median overall survival for patients with endometriosis was 115 months, an increase of 52 months when compared with 63 months for patients without endometriosis. The 5-year survival rate in patients with endometriosis was 70.2%, while it was 52.6% for those without. Univariate and multivariate analysis showed that coexisting endometriosis was not an independent predictor of survival outcome. Tumor stage and optimal debulking were the independent prognostic factors for both overall survival and progression-free survival.
Conclusion(s): Patients with ovarian CCC and coexisting endometriosis had distinct clinicopathological features and better survival outcome. However, endometriosis per se did not confer improved survival.
Keywords: Epithelial ovarian cancer; clear cell adenocarcinoma; clinicopathological features; endometriosis; prognosis.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.Am J Surg Pathol. 2012 May;36(5):688-95. doi: 10.1097/PAS.0b013e31824b6eed. Am J Surg Pathol. 2012. PMID: 22498820
-
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study.Gynecol Oncol. 2014 Jun;133(3):480-4. doi: 10.1016/j.ygyno.2014.03.017. Epub 2014 Mar 15. Gynecol Oncol. 2014. PMID: 24642093
-
The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.Int J Gynaecol Obstet. 2019 Aug;146(2):177-183. doi: 10.1002/ijgo.12861. Epub 2019 May 29. Int J Gynaecol Obstet. 2019. PMID: 31081117
-
Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.Gynecol Oncol. 2014 Mar;132(3):760-6. doi: 10.1016/j.ygyno.2014.01.012. Epub 2014 Jan 16. Gynecol Oncol. 2014. PMID: 24440832 Review.
-
[The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].Nihon Rinsho. 2001 Jan;59 Suppl 1:213-6. Nihon Rinsho. 2001. PMID: 11235169 Review. Japanese. No abstract available.
Cited by
-
Association Between Endometriosis and Prognosis of Ovarian Cancer: An Updated Meta-Analysis.Front Oncol. 2022 Mar 31;12:732322. doi: 10.3389/fonc.2022.732322. eCollection 2022. Front Oncol. 2022. PMID: 35433452 Free PMC article.
-
Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea.Front Oncol. 2022 Apr 7;12:874037. doi: 10.3389/fonc.2022.874037. eCollection 2022. Front Oncol. 2022. PMID: 35463304 Free PMC article.
-
A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update.Reprod Health. 2018 May 21;15(1):82. doi: 10.1186/s12978-018-0506-7. Reprod Health. 2018. PMID: 29783992 Free PMC article. Review.
-
Salvage Chemotherapy for Patients With Recurrent or Persistent Ovarian Clear Cell Carcinoma: A Retrospective Study of 164 Cases.Medicine (Baltimore). 2015 Jul;94(27):e1121. doi: 10.1097/MD.0000000000001121. Medicine (Baltimore). 2015. PMID: 26166110 Free PMC article.
-
Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma.Br J Cancer. 2022 May;126(8):1215-1223. doi: 10.1038/s41416-022-01705-w. Epub 2022 Jan 18. Br J Cancer. 2022. PMID: 35043008 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical